A study performed a CRISPR genetic screen in a mouse model of T1D and confirmed that deletion of RNLS, a candidate gene for genome‐wide association studies in T1D, enables β‐cells to resist killing by autoimmunity and that RNLS is a potential therapeutic target to avoid β‐cell loss in T1D.370. This evidence concerns the gene RNLS and Autoimmunity.